AIM movers: Renalytix FDA approval and share suspensions on the cards

Renalytix (LON: RENX) has been granted US FDA marketing authorisation for KidneyIntelX prognostic testing platform for kidney disease. This will lead to greater use in testing and insurance coverage. The share price jumped 50% to 112.5p.

AMTE Power (LON: AMTE) was awarded a £389,000 grant by the UK Battery Industrialisation Centre yesterday. The company anticipates UN certification of its Ultra High Power Cells in the third quarter of 2023. This has perked up the share price by 16.7% to 7p, but the future of the company remains uncertain.

- Advertisement -

Revolution Beauty (LON: REVB) has hit back at boohoo (LON: BOO) which it says has failed to engage in discussions. The cosmetics supplier criticises boohoo’s failure to set out a strategy and points out that the online retailer has a patchy corporate governance record. The share price continues to improve following the return from suspension. It is off the high for the day but still 15.8% ahead at 31.85p.

Shares in tinyBuild (LON: TBLD) recovered 16.4% to 8.5p after yesterday’s slump because the first half trading performance was below expectations. New video games have underperformed. Higher amortisation of development costs and increased royalties mean that EBITDA will fall more sharply than revenues.

Trackwise Designs (LON: TWD) still has not published 2022 accounts and trading in the shares will be suspended on 3 July. A 2022 operating loss of £2.95m is anticipated. The electric vehicle contract is still delayed. Trackwise Designs has received a purchase order from an aerospace company for qualification test samples. The share price slumped 51.3% to 0.195p.

Phosphate producer Kropz (LON: KRPZ) is another company heading for a share suspension on Monday because the audit of its accounts has not finished. A further 33,000 tonnes of phosphate was sold in June, taking the total for the year to 130,000 tonnes. The share price is 35.5% lower at 2p.

- Advertisement -

Harvest Minerals (LON: HMI) increased fertiliser revenues from $4.86m to $8.63m in 2022 and it moved into profit. However, the Brazil-based company says fertiliser sales invoiced and delivered total 27,000 tonnes, which is well below the budget of 60,000 tonnes. Farmers are expecting the price to drop and delaying purchases. There are 33,000 tonnes invoiced last year that will be included in revenues. Full year invoiced sales guidance has been cut from 200,000 tonnes to 120,000 tonnes.  This knocked the share price by 33.5% to 3.125p.

Caspian Sunrise (LON: CASP) says that it hopes to publish 2022 accounts next week, but trading in the shares could be suspended on 3 July prior to publication. The company is selling oil on the domestic market because of the knock-on effect of sanctions on Russia. That means that Caspian Sunrise is losing an estimated $18m in annual revenues. The $22.5m payment for the sale of 50% of Caspian Explorer is yet to be received and dividend payments have been suspended. The share price fell 21.3% to 3.15p.

Latest News

Subscribe to the UK Investor Magazine email newsletter

Register for our free email newsletter and receive the latest investment news, podcasts, event information and offers.

More Articles Like This

Tagdiv Cloud library - template content.